Trimethyl-[(E)-[(2R)-2-methyl-2-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]cyclohexylidene]methyl]silane
C20H38O2Si — CID 10497259
Data last refreshed: (MolForge compound catalog, from PubChem)
About Trimethyl-[(E)-[(2R)-2-methyl-2-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]cyclohexylidene]methyl]silane
Trimethyl-[(E)-[(2R)-2-methyl-2-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]cyclohexylidene]methyl]silane (PubChem CID 10497259) has the molecular formula C20H38O2Si and a molecular weight of 338.61 g/mol. Its IUPAC name is trimethyl-[(E)-[(2R)-2-methyl-2-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]cyclohexylidene]methyl]silane.
Molecular Properties
| Compound Name | Trimethyl-[(E)-[(2R)-2-methyl-2-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]cyclohexylidene]methyl]silane |
|---|---|
| PubChem CID | 10497259 |
| Molecular Formula | C20H38O2Si |
| Molecular Weight | 338.61 g/mol |
| Exact Mass | 338.26 |
| IUPAC Name | trimethyl-[(E)-[(2R)-2-methyl-2-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]cyclohexylidene]methyl]silane |
| SMILES | CC1(C)COC(C)(CC[C@@]2(C)CCCC/C2=C\[Si](C)(C)C)OC1 |
| InChI | InChI=1S/C20H38O2Si/c1-18(2)15-21-20(4,22-16-18)13-12-19(3)11-9-8-10-17(19)14-23(5,6)7/h14H,8-13,15-16H2,1-7H3/b17-14+/t19-/m1/s1 |
| InChIKey | BPSITIRYVSYNBP-DQSGYLJSSA-N |
| XLogP | 5.94 |
| TPSA | 18.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 338.61 |
| LogP ≤ 5 | 5.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 10497259 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.